GSA Capital Partners’s Evolv Technologies EVLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.45M Buy
238,763
+206,998
+652% +$1.21M 0.09% 300
2025
Q4
$227K Buy
+31,765
New +$226K 0.02% 1333
2025
Q3
Sell
-19,237
Closed -$120K 1779
2025
Q2
$120K Buy
+19,237
New +$89K 0.01% 1597
2025
Q1
Sell
-447,418
Closed -$1.77M 1773
2024
Q4
$1.77M Sell
447,418
-436,806
-49% -$1.53M 0.13% 120
2024
Q3
$3.58M Buy
884,224
+543,322
+159% +$1.9M 0.27% 20
2024
Q2
$869K Buy
+340,902
New +$1.13M 0.06% 594
2023
Q4
Sell
-283,981
Closed -$1.38M 1618
2023
Q3
$1.38M Buy
283,981
+156,911
+123% +$966K 0.12% 251
2023
Q2
$762K Buy
127,070
+63,375
+99% +$300K 0.08% 464
2023
Q1
$199K Buy
+63,695
New +$182K 0.02% 1259

Other funds holding EVLV

GSA Capital Partners's EVLV Position: Q1 2026 in Review

GSA Capital Partners increased its Evolv Technologies (EVLV) stake by 652% in Q1 2026, buying an estimated $1.21M and bringing the position to 238,763 shares worth $1.45M. The position accounts for 0.09% of the portfolio, ranked #300.

GSA Capital Partners first reported a position in EVLV in Q1 2023 and has held it in 9 quarters since. The position peaked at $3.58M in Q3 2024. 260 funds tracked by Wall St. Rank hold EVLV as of Q1 2026.

  • GSA Capital Partners held 238,763 shares of Evolv Technologies worth $1.45M as of Q1 2026.
  • GSA Capital Partners bought 206,998 Evolv Technologies shares in Q1 2026, an estimated $1.21M.
  • Evolv Technologies made up 0.09% of GSA Capital Partners's portfolio in Q1 2026, its #300 holding.
  • GSA Capital Partners first reported a position in Evolv Technologies in Q1 2023 and has held it in 9 quarters since.
  • GSA Capital Partners's Evolv Technologies position peaked at $3.58M in Q3 2024.
  • 260 funds tracked by Wall St. Rank held Evolv Technologies as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.